CytoDyn Inc. (CYDY)

USD 0.23

(-1.61%)

Long Term Debt Summary of CytoDyn Inc.

  • CytoDyn Inc.'s latest annual long term debt in 2024 was 141 Thousand USD , down -100.0% from previous year.
  • CytoDyn Inc.'s latest quarterly long term debt in 2024 FY was 141 Thousand USD , down -85.86% from previous quarter.
  • CytoDyn Inc. reported annual long term debt of 997 Thousand USD in 2023, up 136.26% from previous year.
  • CytoDyn Inc. reported annual long term debt of 422 Thousand USD in 2022, down -23.55% from previous year.
  • CytoDyn Inc. reported quarterly long term debt of 247 Thousand USD for 2024 Q1, down -100.0% from previous quarter.
  • CytoDyn Inc. reported quarterly long term debt of 211 Thousand USD for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of CytoDyn Inc. (2024 - 2004)

Historical Annual Long Term Debt of CytoDyn Inc. (2024 - 2004)

Year Long Term Debt Long Term Debt Growth
2024 141 Thousand USD -100.0%
2023 997 Thousand USD 136.26%
2022 422 Thousand USD -23.55%
2021 552 Thousand USD -93.5%
2020 8.49 Million USD 1768.58%
2019 454.56 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 2.63 Million USD 12.78%
2014 2.33 Million USD 102.83%
2013 1.15 Million USD 12711.3%
2012 9000.00 USD 29.74%
2011 6937.00 USD 0.0%
2010 6937.00 USD -97.55%
2009 283.42 Thousand USD -61.64%
2008 738.76 Thousand USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%

Peer Long Term Debt Comparison of CytoDyn Inc.

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -1662.5%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 91.968%
Qrons Inc. 80 Thousand USD -76.25%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.306%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD 17.655%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.326%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -140.442%
Mesoblast Limited 100.29 Million USD 99.859%
Marizyme, Inc. 667.12 Thousand USD 78.865%
Genus plc 228.2 Million USD 99.938%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.915%
Therapeutic Solutions International, Inc. 5512.00 USD -2458.055%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 93.62%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 89.95%
IMV Inc. 27.39 Million USD 99.485%
AXIM Biotechnologies, Inc. 5.42 Million USD 97.402%
MultiCell Technologies, Inc. 36.43 USD -386943.645%
ONE Bio Corp. 592.19 Thousand USD 76.19%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.746%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 93.666%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 88.521%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 74.576%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -457.334%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 92.573%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 56.211%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.999%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD 6.0%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 14.132%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 99.082%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -3064.273%
Genscript Biotech Corporation 287.12 Million USD 99.951%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -11.637%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 38.506%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 38.613%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 98.294%
BioStem Technologies, Inc. 265.63 Thousand USD 46.92%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -13151.88%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 5.757%
Regen BioPharma, Inc. 149.61 Thousand USD 5.757%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 98.197%
SYBLEU INC 300 Thousand USD 53.0%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 61.794%
International Stem Cell Corporation 445 Thousand USD 68.315%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 98.27%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 69.147%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 87.855%
PureTech Health plc 18.25 Million USD 99.227%
Coeptis Therapeutics, Inc. 150 Thousand USD 6.0%
IXICO plc 275 Thousand USD 48.727%
IntelGenx Technologies Corp. 11.83 Million USD 98.809%
Gelesis Holdings, Inc. 26.3 Million USD 99.464%
CSL Limited 11.23 Billion USD 99.999%
Cellectis S.A. 36.21 Million USD 99.611%